VIEW NOW—Clinically Actionable Genomics: From Sequencing to Personalized Medicine

June 18, 2014
VIEW NOW—Clinically Actionable Genomics: From Sequencing to Personalized Medicine
Appistry's CSO Richard Mazzarella, Ph.D., and Cancer Genetics' Molecular Diagnostics Director Weiyi Chen, Ph.D., are speakers.

The DxMA webcast "Clinically Actionable Genomics: From Sequencing to Personalized Medicine" sponsored by Clinical OMICs is now available for viewing. This webcast focuses on describing the technologies and strategies—such as genome sequencing, massive amounts of genetic data, bioinformatics, and analytics—that are transforming genomic data into clinically actionable intelligence.

You will learn:

  • How new gene-based tests have transformed diagnosis, prognostication, risk assessment, and treatment of some cancers
  • How informatics companies are developing and delivering reports incorporating tests, sequencing, analysis, and interpretation for physicians
  • What future tests are currently in development

Who should watch:

  • Pathologists
  • Oncologists
  • Cancer drug developers
  • Clinical laboratory scientists

CLICK HERE to view the webcast.

×

Oops! Please type your email in the following format: [email protected]

You’re all set!
Thank you for subscribing to
Clinical OMICs Weekly
.